| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.17 | 8e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.12 | 8e-05 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |